加载中
NASDAQHealthcareMedical - Healthcare Information Services
最新数据
US$0.9763
−US$0.0037 · -0.38%
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
收盘时
US$0.9763
−US$0.0037 · -0.38%
盘后
US$0.9661
−US$0.0102 · -1.04%
10月12日 19:45 ET
盘中时间采用ET。市场数据可能有所延迟。
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
日内区间
当前US$0.9763
52周区间
当前US$0.9763
盘中时间采用ET。市场数据可能有所延迟。
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
日内区间
当前US$0.9763
52周区间
当前US$0.9763
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 2.42亿 USD | 2.52亿 USD | 2.51亿 USD | 2.23亿 USD | 1.66亿 USD |
| 销货成本 | 5824.6万 USD | 5473.3万 USD | 4748.2万 USD | 4262.5万 USD | 4068.9万 USD |
| 毛利 | 1.83亿 USD | 1.97亿 USD | 2.04亿 USD | 1.8亿 USD | 1.25亿 USD |
| 研究与开发 | 3477.6万 USD | 3651.8万 USD | 4244.1万 USD | 3489万 USD | 1856.5万 USD |
| 销售、一般及管理费用 | 1.33亿 USD | 1.33亿 USD | 1.53亿 USD | 1.41亿 USD | 8925.1万 USD |
| 营业费用 | 2.04亿 USD | 9.08亿 USD | 5.34亿 USD | 2.24亿 USD | 1.53亿 USD |
| 利息收入 | 695.1万 USD | 1459.2万 USD | 1364.4万 USD | 278.7万 USD | 2.9万 USD |
| 利息支出 | 1128.8万 USD | 1483.7万 USD | 1520.3万 USD | 1120万 USD | 2590万 USD |
| 折旧和摊销 | 5611万 USD | 5166.7万 USD | 5175万 USD | 5690.4万 USD | 5994.7万 USD |
| 营业利润 | −2058.3万 USD | −7.11亿 USD | −3.3亿 USD | −4404.3万 USD | −2731.7万 USD |
| 净利润 | −1.39亿 USD | −4.13亿 USD | −2.02亿 USD | −722.2万 USD | −5190.8万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$1.20
上涨空间 22.91%报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI126.13万0.00%2.3万亿 USD0.03%US$381.57-0.10%
Dimensional - US Small Cap ETFDFAS62.23万0.00%338.69亿 USD0.31%US$78.17-0.23%
Vanguard Extended Market ETFVXF45.38万0.00%954亿 USD0.05%US$233.52-0.63%
U.S. Micro Cap Portfolio ETFDFMC26.93万0.00%75.58亿 USD0.43%US$57.70-0.20%
Dimensional - US Core Equity 2 ETFDFAC20.02万0.00%885.96亿 USD0.21%US$45.31-0.04%
iShares Micro-Cap ETFIWC11.36万0.01%13.17亿 USD0.60%US$181.66-0.73%
WisdomTree U.S. SmallCap FundEES11.24万0.02%6.81亿 USD0.38%US$65.46-0.05%
Invesco RAFI US 1500 Small-Mid ETFPRFZ6.98万0.00%26.7亿 USD0.36%US$52.92-0.45%Vanguard Morningstar Total Stock Market ETFVTIDimensional - US Small Cap ETFDFASVanguard Extended Market ETFVXFU.S. Micro Cap Portfolio ETFDFMCDimensional - US Core Equity 2 ETFDFACiShares Micro-Cap ETFIWCWisdomTree U.S. SmallCap FundEESInvesco RAFI US 1500 Small-Mid ETFPRFZAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
